Men’s Health Awareness Week
Elevating Prostate Cancer Diagnosis Through Radiology Excellence
Men’s Health Awareness Week, held each June, is a vital reminder of the health challenges men face — and the importance of early detection, accurate diagnosis, and equitable access to care. Among these challenges, prostate cancer remains one of the most significant, standing as the most commonly diagnosed cancer in men across Australia and New Zealand.
In 2026, more than 25,000 men across the region are expected to receive a prostate cancer diagnosis. While survival rates continue to improve, outcomes still depend heavily on one critical factor: accurate staging at the time of diagnosis. This is where Radiologists play a transformative role.
🌍 Prostate Cancer - The Numbers That Matter
Prostate cancer is not only common — it is complex. Key statistics highlight the urgency:
1 in 6 men in Australia and New Zealand will be diagnosed in their lifetime
Over 4,000 men across both countries die from prostate cancer each year
When detected early and staged accurately, the 5‑year survival rate exceeds 95%
Advanced or metastatic disease still accounts for a significant proportion of late diagnoses
These numbers underscore the need for precision in imaging, reporting, and staging — the foundation of every treatment decision that follows.
🩻 How Radiologists Diagnose and Stage Prostate Cancer
Radiologists are central to the prostate cancer pathway. Modern diagnosis relies on a combination of:
Multiparametric MRI (mpMRI)
The gold standard for:
Lesion detection
PI‑RADS scoring
Guiding targeted biopsy
Assessing extracapsular extension
PSMA PET/CT
Increasingly essential for:
Nodal staging
Detecting micrometastatic disease
Treatment planning and therapy selection
Structured reporting
Including:
PI‑RADS v2.1
TNM staging
Standardised terminology for multidisciplinary teams
Why accuracy matters
A single staging discrepancy can alter:
Surgical planning
Radiotherapy fields
Systemic therapy decisions
Patient prognosis
Radiologists are not just image interpreters. They are key decision‑makers in the prostate cancer journey.
🧠 Introducing PROSTATERAD 2027: Advancing Prostate Imaging Excellence
To support Radiologists across Australia and New Zealand in delivering the highest standard of prostate cancer diagnosis, we are proud to announce the launch of the:
PROSTATERAD Imaging Workshop (27–28 February 2027)
This two‑day, expert‑led workshop is designed to strengthen confidence, consistency, and accuracy in prostate cancer imaging and staging. What PROSTATERAD 2027 will deliver:
Deep‑dive mpMRI interpretation training
PSMA PET/CT case‑based learning
Hands‑on staging exercises using real clinical scenarios
Updates on PI‑RADS, TNM, and emerging imaging biomarkers
Multidisciplinary perspectives from urologists, oncologists, and radiographers
Next‑step pathways for patient management after imaging
Our goal is simple: To empower Radiologists with the skills and clarity needed to deliver the most accurate prostate cancer diagnoses — improving outcomes for thousands of men each year.
📣 Why We’re Launching PROSTATERAD During Men’s Health Awareness Week
Men’s Health Awareness Week is about more than raising awareness — it’s about taking action.
By launching PROSTATERAD 2027 during this important week, we are reinforcing our commitment to:
Earlier detection
More accurate staging
Better treatment decisions
Improved survival and quality of life for men
Radiologists are at the heart of this mission. When imaging is precise, patient care becomes powerful.
💬 Join Us in February 2027
As prostate cancer rates continue to rise, the demand for highly skilled Radiologists has never been greater. PROSTATERAD 2027 is your opportunity to sharpen your expertise, connect with peers, and contribute to a future where every man receives the most accurate diagnosis possible.
Together, we can elevate prostate cancer care across Australia and New Zealand — one diagnosis at a time.